1. Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? 
Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho, Bengt Lindholm 
Kidney International 
Volume 61, Pages S103-S108 (May 2002)
DOI: /j s80.19.x
Copyright © 2002 International Society of Nephrology Terms and Conditions

2. Figure 1
Kaplan-Meier survival analysis showing the outcome of 147 ESRD patients followed after start of renal replacement therapy. The patient material is divided into quartiles according to basal levels of interleukin-6. The survival rate is statistically different (Chi-square 27.5; P < ) between the groups.
Kidney International  , S103-S108DOI: ( /j s80.19.x)
Copyright © 2002 International Society of Nephrology Terms and Conditions

3. Figure 2
Regression analyses showing a positive correlation (R = 0.44;P < 0.01) between Log interleukin-6 and soluble intracellular adhesion molecule (sICAM-1) levels in 48 ESRD patients close to start of dialysis treatment.
Kidney International  , S103-S108DOI: ( /j s80.19.x)
Copyright © 2002 International Society of Nephrology Terms and Conditions